In this minisode, Mindy is joined by Vynamic’s Brian Schachter to discuss a few recent newsworthy items including: the Inflation Reduction Act signed by President Biden (00:50), the FDA granting Zynteglo a priority review (09:01), and the primary care market that is being reinvigorated by new entrants who are placing big bets on the healthcare system (14:40).
Podcast Tags: healthcare, healthcare news, life sciences, Inflation Reduction Act, Medicare, Zynteglo, primary care, value-based care, BlueBird Bio
Source Links:
· https://www.cnn.com/2022/08/07/politics/senate-democrats-climate-health-care-bill-vote/index.html
· https://www.cbsnews.com/news/insulin-price-cap-senate-republicans-block-inflation-reduction-act/
· https://www.google.com/search?q=FDA+to+approve+zynteglo
· https://endpts.com/bluebird-bio-may-finally-get-a-gene-therapy-approved-in-the-us/
· https://www.fiercepharma.com/pharma/cell-and-gene-therapy-makers-push-past-regulatory-payer-hurdles
· https://www.fiercehealthcare.com/providers/retailers-payers-and-startups
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Ryan Hummel, Executive and Head of Provider Sector
Brian Schachter, Manager
Listen now
Naseem Ahmed appointed judge for the BPLS Inspire Awards
Inizio’s Global Director of Inclusion and Impact, Naseem Ahmed, has been appointed as a judge for the BPLS Inspire Awards.
Read moreSpeed to publication with GenAI: Done the right way
In the last three years, Generative AI (GenAI) has moved from novelty to expectation. Across industries, teams are being asked, whether explicitly or
Read moreInizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read more